Danazol

ATC Code G03XA01

Danazol

Definition

A synthetic androgen derived from ethinyl testosterone. Danazol indirectly reduces estrogen production by decreasing pituitary secretion of follicle-stimulating hormone and luteinizing hormone, and binds to sex hormone receptors in target tissues, thereby exhibiting antiestrogenic, anabolic and weakly androgenic effects. (NCI04)

Also known as (17Alpha)-pregna-2,4-dien-20-yno[2,3-d]-isoxazol-17-ol, (17alpha)-Pregna-2,4-dien-20-yno[2,3-d]isoxazol-17-ol, 1-Ethynyl-2,3,3a,3b,4,5,10,10a,10b,11,12,12a-dodecahydro-10a,12a-dimethyl-1H-cyclopental[7,8]phenanthro[3,2-d]isoxazol-1-ol, 17Alpha-ethynyl-17beta-hydroxy-4-androsteno[2,3-d]isoxazole, Bonzol, Chronogyn, Cyclomen, DAN, DANAZOL, Danocrine, Danol, Danoval, Ladogal, Win 17757, Win-17757, Winobanin — per NCIT

Also identified as

Indications

Disease Relation Source
Angioedema may prevent MEDRT · Public domain (U.S. Government work)
Breast fibrocystic disease may treat MEDRT · Public domain (U.S. Government work)
Endometriosis may treat MEDRT · Public domain (U.S. Government work)

Organ Effects

Organ Side effect / interaction Source
Breast may treat a disease of this organ DERIVED · CC BY 4.0
Female reproductive system may treat a disease of this organ DERIVED · CC BY 4.0
Genitourinary system may treat a disease of this organ DERIVED · CC BY 4.0
Reproductive system may treat a disease of this organ DERIVED · CC BY 4.0

4 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.